...
首页> 外文期刊>Ethiopian journal of health sciences >HIV Care continuum Outcomes: Can Ethiopia Meet the UNAIDS 90-90-90 Targets?
【24h】

HIV Care continuum Outcomes: Can Ethiopia Meet the UNAIDS 90-90-90 Targets?

机译:艾滋病毒护理连续核算结果:埃塞俄比亚是否会遇到艾滋病规划署90-90-90目标?

获取原文
           

摘要

Background Ethiopia has pledged to the UNAIDS 90-90-90 framework. However, the achievements of these UNAIDS targets are not assessed in Southwest Ethiopia. Using HIV care and treatment outcomes as surrogate markers, we assessed all targets. Methods Complex surrogate makers were used to assess the HIV care continuum outcomes using antiretroviral therapy data in Jimma University Teaching Hospital. Early HIV diagnosis was a surrogate marker to measure the first 90. Numbers of people on HIV treatment and who have good adherence were used to measure the second 90. To measure the third 90, we used immunological success that was measured using numbers of CD4 counts, clinical success using WHO clinical stages and treatment success using immunological and clinical successes. Results In total, 8172 patients were enrolled for HIV care from June 2003 to March 2015. For the diagnosis target, the prevalence of early HIV diagnosis among patients on ART was 35% (43% among children and 33.3% among adults). For the treatment target, 5299(65%) received ART of which 1154(22%) patients lost to follow-up or defaulted from ART treatment, and 1015(19%) patients on treatment transferred out to other sites. In addition, 17% had fair or good adherence. Finally, 81% had immunological success, 80% had clinical success and 66% treatment success. Conclusions The study revealed that Southwest Ethiopia achieved 35%, 65% and 66% of the first, second and third UNAIDS targets, a very far performance from achieving the target. These highlight further rigorous interventions to improve outcome of HIV continuum of care.
机译:背景技术埃塞俄比亚已向艾滋病规划署框架造成框架。然而,在埃塞俄比亚西南部的艾滋病规划署目标的成就不会评估。使用艾滋病毒护理和治疗结果作为替代标记,我们评估了所有目标。方法采用吉米大学教学医院的抗逆转录病毒治疗数据评估复杂的代理制造商来评估艾滋病毒护理连续因素。早期的艾滋病毒诊断是替代标记,以衡量第90次艾滋病毒治疗的人数,并且使用良好的遵守措施来测量第二个90.为了测量第三种90,我们使用使用CD4计数的数量测量的免疫学成功,使用免疫学和临床成功使用临床阶段和治疗成功的临床成功。结果总计8172名患者于2003年6月至2015年3月均为艾滋病毒保健。对于诊断目标,艺术患者早期艾滋病病毒诊断的患病率为35%(儿童43%,成年人33.3%)。对于治疗目标,5299(65%)接受的艺术,其中1154名(22%)患者失去的术语或违约的患者,1015(19%)患者对其他地点转移出来。此外,17%有公平或良好的依从性。最后,81%的免疫学成功,80%的临床成功和66%的治疗成功。结论该研究表明,西南埃塞俄比亚实现了第一个,第二和第三艾滋病规划署目标的35%,65%和66%,这是实现目标的远远效果。这些突出了进一步严谨的干预措施,以改善艾滋病毒连续性的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号